Singapore markets closed

INMD Jan 2024 220.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
36.000.00 (0.00%)
As of 09:08AM EST. Market open.
Full screen
Previous close36.00
Open36.00
Bid0.00
Ask0.00
Strike220.00
Expiry date2024-01-19
Day's range36.00 - 36.00
Contract rangeN/A
Volume1
Open interest2
  • Motley Fool

    2 No-Brainer Stocks to Buy Now That Could Soar in 2023

    As the year winds down, investors may be looking forward to 2023 and hoping for a better year in the stock market. Part of this growth is due to sales of consumables, which increased 53% year over year, outpacing revenue growth.

  • CNW Group

    InMode Receives Health Canada Certification of Forma-I for Dry Eye Disease Due to Meibomian Gland Dysfunction

    InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, is proud to announce the Health Canada license of the Forma-I to address the symptoms of dry eye disease due to Meibomian gland dysfunction (MGD). Forma-I is intended for use in the periorbital area and eyelids and relieves inflammation of meibomian glands and eye irritation.

  • Motley Fool

    Is InMode Stock a Buy Now?

    InMode (NASDAQ: INMD) is a medical device company that provides its consumers with a wide range of treatments to help with contouring skin, treating acne, removing hair, and other aesthetic issues. InMode operates in an area of healthcare -- aesthetics -- that is proving to be strong amid inflation; in its most recent quarter (the period ended Sept. 30), the company reported revenue of $121.1 million, which was up 29% year over year.